Annarita Farina

Annarita Farina

Auto-generated profile, based on publicly available information

Annarita Farina

Biomedical Proteomics Research Group, Department of Human Protein Sciences, Geneva University, Geneva CH-1211, Switzerland

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2013 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
VSV Severino
V Severino
Nicola AlessioNicola Alessio
Nicola Alessio
AFA Farina
A Farina
Annamaria SandomenicoAnnamaria Sandomenico
Annamaria Sandomenico
MCM Cipollaro
M Cipollaro
Angela ChamberyAngela Chambery
Angela Chambery
Cellular senescence is the permanent arrest of cell cycle, physiologically related to aging and aging-associated diseases. Senescence is also recognized as a mechanism for limiting the regenerative potential of stem cells and to protect cells from cancer development. The senescence program is realized through autocrine/paracrine pathways based on the activation of a peculiar senescence-associated secretory phenotype (SASP). We show here that conditioned media (CM) of senescent mesenchymal stem cells (MSCs) contain a set of secreted factors that are able to induce a full senescence response in young cells. To delineate a hallmark of stem cells SASP, we have characterized the factors secreted by senescent MSC identifying insulin-like growth factor binding proteins 4 and 7 (IGFBP4 and IGFBP7) as key components needed for triggering senescence in young MSC. The pro-senescent effects of IGFBP4 and IGFBP7 are reversed by single or simultaneous immunodepletion of either proteins from senescent-CM. The blocking of IGFBP4/7 also reduces apoptosis and promotes cell growth, suggesting that they may have a pleiotropic effect on MSC biology. Furthermore, the simultaneous addition of rIGFBP4/7 increased senescence and induced apoptosis in young MSC. Collectively, these results suggest the occurrence of novel-secreted factors regulating MSC cellular senescence of potential importance for regenerative medicine and cancer therapy.

1 April 2013 in Journal of Proteomics
Verified
Journal Article
Closed access
MPMarco Prunotto
Marco Prunotto
AFAnnarita Farina
Annarita Farina
LLLydie Lane
Lydie Lane
APAgnès Pernin
Agnès Pernin
JSJürg Schifferli
Jürg Schifferli
SMSolange Moll
Solange Moll

14 January 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LSLaurent Spahr
Laurent Spahr
Yves ChalandonYves Chalandon
Yves Chalandon
STSylvain Terraz
Sylvain Terraz
VKVincent Kindler
Vincent Kindler
LRLaura Rubbia-Brandt
Laura Rubbia-Brandt
AHAntoine Hadengue
Antoine Hadengue
Impaired liver regeneration is associated with a poor outcome in patients with decompensated alcoholic liver disease (ALD). We assessed whether autologous bone marrow mononuclear cell transplantation (BMMCT) improved liver function in decompensated ALD. 58 patients (mean age 54 yrs; mean MELD score 19, all with cirrhosis, 81% with alcoholic steatohepatitis at baseline liver biopsy) were randomized early after hospital admission to standard medical therapy (SMT) alone (n = 30), including steroids in patients with a Maddrey’s score ≥32, or combined with G-CSF injections and autologous BMMCT into the hepatic artery (n = 28). Bone marrow cells were harvested, isolated and reinfused the same day. The primary endpoint was a ≥3 points decrease in the MELD score at 3 months, corresponding to a clinically relevant improvement in liver function. Liver biopsy was repeated at week 4 to assess changes in Ki67+/CK7+ hepatic progenitor cells (HPC) compartment. Both study groups were comparable at baseline. After 3 months, 2 and 4 patients died in the BMMCT and SMT groups, respectively. Adverse events were equally distributed between groups. Moderate alcohol relapse occurred in 31% of patients. The MELD score improved in parallel in both groups during follow-up with 18 patients (64%) from the BMMCT group and 18 patients (53%) from the SMT group reaching the primary endpoint (p = 0.43 (OR 1.6, CI 0.49–5.4) in an intention to treat analysis. Comparing liver biopsy at 4 weeks to baseline, steatosis improved (p<0.001), and proliferating HPC tended to decrease in both groups (−35 and −33%, respectively). Autologous BMMCT, compared to SMT is a safe procedure but did not result in an expanded HPC compartment or improved liver function. These data suggest either insufficient regenerative stimulation after BMMCT or resistance to liver regenerative drive in patients with decompensated alcoholic cirrhosis. Controlled-Trials.com ISRCTN83972743.

1 August 2017 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
VSValeria Severino
Valeria Severino
JDJean-Marc Dumonceau
Jean-Marc Dumonceau
MDMyriam Delhaye
Myriam Delhaye
SMSolange Moll
Solange Moll
IAIsabelle Annessi-Ramseyer
Isabelle Annessi-Ramseyer
AFAnnarita Farina
Annarita Farina

1 June 2009 in Expert Review of Proteomics
Verified
Journal Article
Closed access
AFAnnarita Farina
Annarita Farina
JDJean-Marc Dumonceau
Jean-Marc Dumonceau
PLPierre Lescuyer
Pierre Lescuyer
Bile is a body fluid produced by the liver and drained by biliary ducts into the duodenum. It has two major functions: first, it contains bile acids, which are critical for the digestion of fats, and second, it is an excretory pathway for many endogenous and exogenous compounds. Proteomic analysis of bile is particularly difficult since this fluid contains high concentrations of various substances that strongly interfere with protein separation and identification techniques. Furthermore, owing to its deep location in the body, bile must be collected by surgical or endoscopic procedures. However, as was speculated for other body fluids, bile appears to be a promising sample for the discovery of disease biomarkers leaking from proximal tissues: the liver, pancreas or biliary tree. The interest in clinical proteomics was demonstrated by two studies that identified in bile potential biomarkers for two deadly and difficult to diagnose neoplasms, pancreatic cancer and cholangiocarcinoma.

21 October 2014 in Microbiologyopen
Verified
Journal Article
Open access
PDF file
EJEsther Jimenez
Esther Jimenez
BSBorja Sanchez
Borja Sanchez
AFAnnarita Farina
Annarita Farina
AMAbelardo Margolles
Abelardo Margolles
JRJuan Miguel Rodríguez
Juan Miguel Rodríguez
Bile is a biological fluid synthesized in the liver, stored and concentrated in the gall bladder (interdigestive), and released into the duodenum after food intake. The microbial populations of different parts of mammal's gastrointestinal tract (stomach, small and large intestine) have been extensively studied; however, the characterization of bile microbiota had not been tackled until now. We have studied, by culture-dependent techniques and a 16S rRNA gene-based analysis, the microbiota present in the bile, gall bladder mucus, and biopsies of healthy sows. Also, we have identified the most abundant bacterial proteins in the bile samples. Our data show that the gall bladder ecosystem is mainly populated by members of the phyla Proteobacteria, Firmicutes, and Bacteroidetes. Furthermore, fluorescent in situ hybridization (FISH) and transmission electron microscopy (TEM) allowed us to visualize the presence of individual bacteria of different morphological types, in close association with either the epithelium or the erythrocytes, or inside the epithelial cells. Our work has generated new knowledge of bile microbial profiles and functions and might provide the basis for future studies on the relationship between bile microbiota, gut microbiota, and health.